The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126819771 12681977 1 I 20160818 20160824 20160824 EXP PL-MYLANLABS-2016M1035680 MYLAN HANNA K-J, AGNIESZKA K-P, MICHAL D, DARIUSZ J, IZABELA D, AGATA M, ET AL. AFFECTIVE DISORDERS AS POTENTIAL COMPLICATION OF ANTI-ACNE TREATMENT WITH ISOTRETINOIN: A CASE SERIES. J-AFFECT-DISORD 2016;204:154-158. 0.00 Y 0.00000 20160824 OT PL PL

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126819771 12681977 1 PS ISOTRETINOIN ISOTRETINOIN 1 Oral 60 MG/DAY U 75945

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126819771 12681977 1 Acne

Outcome of event

Event ID CASEID OUTC COD
126819771 12681977 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
126819771 12681977 Bipolar I disorder
126819771 12681977 Suicidal ideation

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found